Welcure Drugs & Pharmaceuticals Ltd.

WELCURE

₹6.64

4.9% (0.31)

Market Cap

₹74 Cr.

P/E

2.64

Welcure Drugs & Pharmaceuticals Ltd.
Overview
Financials
Benchmarking
Shareholding

Key Ratios

Edit Ratio's

Market cap

74.00 Cr

2.64

Prom Holding

ROE (%)

-13.06

ROCE (%)

-13.06

Div Yield (%)

Sales

354 Cr

OPM (%)

9.74 %

Debt to Equity

Edit Ratio's

About

Welcure Drugs & Pharmaceuticals Ltd specializes in manufacturing and marketing a wide range of… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

3 No

Negative for this company

3 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Capex vs ROCE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Welcure Drugs & Pharmaceuticals Ltd. Business

What does Welcure Drugs&Pharma do?

Welcure Drugs & Pharmaceuticals Ltd manufactures and markets over hundred varieties of pharmaceutical formulations including antibiotics, vitamins, and analgesics in tablets, capsules, and dry syrups.

Who are the competitors of Welcure Drugs&Pharma?

Welcure Drugs&Pharma major competitors are Mishka Fin & Trading, Franklin Industries, Mittal Life Style, Swadeshi Inds & Leas, IMEC Services, Dhanalaxmi Roto Spin, Novelix Pharma.
Market Cap of Welcure Drugs&Pharma is ₹71 Crs.
While the median market cap of its peers are ₹67 Crs.

Is Welcure Drugs&Pharma financially stable compared to its competitors?

Welcure Drugs&Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Welcure Drugs&Pharma is 0 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Aug
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Welcure Drugs & Pharmaceuticals Ltd.

Welcure Drugs & Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

10 Yes

1 Neutral

3 No

3 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Pledge

Retail Holding

Promoter Holding

Other Income

Revenue Recognition

Price & Performance

ROE

Share price

Working Capital

Debt

Sales Growth

Balance Sheet Strength

Margin Stability

ROCE Strength

Capex vs ROCE

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Welcure Drugs&Pharma do?

Who are the competitors of Welcure Drugs&Pharma?

Is Welcure Drugs&Pharma financially stable compared to its competitors?

SIGN UP FOR FREE